Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world re-opens for business. However, others may turn out to be classic value traps. Read on for our usual insightful comment.
James Halstead: another dividend increase
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Anexo
Episode 16 of the Investor’s Champion Podcast
In this episode of the Investor’s Champion Podcast Chris and Lee run through key news from…
Radical changes | Stunning results | Another takeover
It’s always extremely difficult for a business to radically change its operating model, but one rental…
More on Brickability
Bigger is not necessarily better
News covered here includes our assessment of results from a cracking little automotive engineering business, although…
Tough to value | AI excitement | Ahead of the pack
Our coverage here focuses on several AIM micro-caps operating in very different sectors. An oil and…
More on Duke Capital
The penny drops | Cash delights | Another AIM takeover
Small cap news covered in our update here includes our forthright assessment of the latest update…
Precarious | Another acquisition target?
Interim results from a heavily indebted flooring company covered here suggest this business is in a…
More on Ideagen PLC
Bonkers deal of the week or another nifty acquisition?
The shares of technology stocks are plummeting, but that hasn’t stopped this AIM company paying what…
Strong updates to enjoy
Results and updates covered here include those of several consistent (and highly-rated) performers, but a potential…
More on iEnergizer
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
More on ITV
Income Boosters: making progress in mixed markets
July was a busy month for our high yield Income Boosters portfolio, with five companies reporting during…
Income Boosters: April ‘24 portfolio update
Our high-yield portfolio offers a well-supported 5.9% yield, with many of our companies trading on attractive…
More on James Halstead
Episode 37 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, hosts Lee and Chris delve into the world…
50 years of growing dividends | Transformational deals worry us
News covered here includes our assessment of results from one of AIM’s highest quality companies, with…
More on Manolete Partners
Episode 39 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, hosts Chris and Lee dive into the controversial…
Improving returns | Questionable business models
A software provider whose results we assess here continues to recover from the consequences of a…
More on WH Smith
Episode 21 of the Investor’s Champion Podcast
In this episode of the Investors Champion podcast, hosts Chris and Lee discuss the challenges faced…
Tale of two retailers | Regulatory approval
News covered here includes our assessment of updates from the retail sector. Two very different businesses…
